🕵️ Treace Medical Concepts, Inc. ($TMCI)
SEC insider & ownership activity, last 12 months · CIK 1630627 · every row links its SEC filing
Over the last 12 months insiders bought $1.2M with no open-market selling against it. John T. Treace bought $1.2M (May–Aug). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $1.2M (12 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| John T. Treace | 12 | $1.2M | 0 | – | Aug 24, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| John T. Treace | 19.2% | 13G | Aug 12, 2026 | filing ↗ | |
| Armistice Capital, LLC | 9.8% | 13G | Aug 14, 2026 | filing ↗ | |
| Steven Boyd | 9.8% | 13G | Aug 14, 2026 | filing ↗ | |
| Neil Gagnon | 9.6% | 13G | Feb 12, 2026 | filing ↗ | |
| Gagnon Securities LLC | 6.2% | 13G | Feb 12, 2026 | filing ↗ | |
| Bank of America Corp /DE/ | 5.5% | 13G | May 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 19, 2026 | filing ↗ |
| Earnings (2.02) | May 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 8, 2026 | filing ↗ |
| Earnings (2.02) | Apr 8, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 8, 2026 | filing ↗ |
| Earnings (2.02) | Feb 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing ↗ |
| Earnings (2.02) | Jan 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 13, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 16, 2025 | filing ↗ |
| Agreement terminated (1.02) | Dec 16, 2025 | filing ↗ |
| New financial obligation (2.03) | Dec 16, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Dec 16, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 16, 2025 | filing ↗ |
| Other events (8.01) | Dec 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 16, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |